What is ANAB's current stock price?

As of now, ANAB is trading at $41.95, with a daily change of +5.91%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ANAB Stock Analysis & IQ Rating | AnaptysBio

ANAB

AnaptysBio

$41.95

+$2.34 | +5.91%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$43.31

MKT CAP

$1.17B

52W Low

$12.21

VOL

$748.60K

P/E Ratio

N/A

AVG VOL

$581.81K

RSI

74.08

TREND

Uptrend

ANAB Stock IQ

Login to see AnaptysBio (ANAB) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ANAB Target Price

Login to display

Not Enough Information

Strengths

ANAB Rewards

Upgraded on attractively valued

ANAB Rewards

Expands stock buyback program

ANAB Rewards

Outperform the market

ANAB Rewards

Earnings are forecast to grow

Chart

$36.16 (+16.01%)

$20.33 (+106.35%)

$23.75 (+76.63%)

$24.85 (+68.81%)

1year

6month

3month

1month

ANAB Risk Level

ANAB has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

High volatilty

Low

LOW

HIGH

ANAB Analysts Opinion

ANAB overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

ANAB Analysts Opinion

ANAB Analysts opinion is positive and also has improved from the past 3 months

ANAB Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

56%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

75%

0%

100%

ANAB Street Sentiment

ANAB Street Sentiment is bullish and have positive views on the near-term outlook

ANAB Performance Sentiment

Sentiments overview associated with ANAB events and the stock performance.

56%

41%

Positive

Negative

15 out of 27
events present

11 out of 27
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$39.61

Resistance
Price

$29.63

Current Price Range

N/A

Show methods +

Linked to ANAB

IQ

Close Price

Change

MLTX

2.97

13.15

+3.79%

ANAB Latest Analysis +

AnaptysBio Buckles After Trading Legal Barbs With Pharma Giant GSK. AnaptysBio stock buckled Friday after the biotech company and GSK filed competing lawsuits against one another over a licensing deal.The post AnaptysBio Buckles After Trading Legal Barbs With Pharma Giant GSK appeared first on Investor'.s Business Daily.

Fri Nov 21, 2025

$39.61 | +5.15%

Activity

GSK Unit Tesaro Sues AnaptysBio Threatening Key Cancer Drug Jemperli Royalties. ) subsidiary ANAB) in the Delaware Chancery Court.ANAB is encountering selling pressure. GSK Tesaro in December 2018 for approximately $5.1 billion (4.0 billion British pounds)The action contends that recent conduct by AnaptysBio is in material breach of the existing license agreement with TESARO regarding the Jemperli (dostarlimab).The breach entitles TESARO to terminate the current license agreement obtain a perp

Fri Nov 21, 2025

$39.61 | +5.15%

Activity

Momentum

AnaptysBio drops as litigation with GSK unit risks cancer therapy deal.

Fri Nov 21, 2025

$39.61 | +5.15%

Momentum

GSK subsidiary TESARO files lawsuit against AnaptysBio over Jemperli license.

Fri Nov 21, 2025

$39.61 | +5.15%

Activity

AnaptysBio stock falls after filing lawsuit against GSK unit.

Fri Nov 21, 2025

$39.61 | +5.15%

Activity

Momentum

AnaptysBio drops after litigation with GSK unit risks cancer therapy deal.

Fri Nov 21, 2025

$39.61 | +5.15%

Momentum

AnaptysBio sets $100M stock repurchase plan.

Fri Nov 21, 2025

$39.61 | +5.15%

Activity

AnaptysBio Approves Amended $100 Mln Stock Repurchase Plan . (RTTNews) - AnaptysBio Inc. (ANAB) a clinical-stage biotechnology company on Friday said its Board has approved an amended stock repurchase plan allowing the company to buy back up to $100 million of its stock.

Fri Nov 21, 2025

$39.61 | +5.15%

Activity

Potential

TESARO Pursues Litigation Against AnaptysBio For Alleged Material Breach Of Jemperli Agreement . (RTTNews) - GSK plc.s (GSK) subsidiary TESARO Inc. has commenced litigation against AnaptysBio Inc. (ANAB) contending that AnaptysBio has materially violated the terms of their licensing agreement related to the oncology drug Jemperli.

Fri Nov 21, 2025

$39.61 | +5.15%

Activity

GSKs Tesaro Sues AnaptysBio Over Jemperli License Dispute . (RTTNews) - GSK plc (GSK) a biopharmaceutical companys subsidiary Tesaro Inc. (TSRO) on Friday announced that it has filed litigation in the Delaware Chancery Court against AnaptysBio Inc. (ANAB) alleging a material breach of their license agreement covering the oncology dr

Fri Nov 21, 2025

$39.61 | +5.15%

Activity

FAQ About ANAB Stock Insights

What is ANAB current stock price?

What are ANAB stock strengths?

What is ANAB Risk Level?

What is ANAB market cap and volume?

What is ANAB current Stock IQ?

Should I buy ANAB stock right now?

Is ANAB a Strong Buy right now?

What does a 'Strong Buy' rating mean for ANAB?

What does a 'Strong Sell' rating mean for ANAB?

What factors influence ANAB's Stock IQ?

Explore our ANAB Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ANAB Stock Strategies
Effective Risk Management

FIND US ON

Receive our ANAB Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ANAB

AnaptysBio

Current Price

$41.95

+$2.34 | +5.91%

52W High

$43.31

MKT CAP

$1.17B

52W Low

$12.21

VOL

$748.60K

P/E Ratio

N/A

AVG VOL

$581.81K

RSI

74.08

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

ANAB Rewards

Upgraded on attractively valued

ANAB Rewards

Expands stock buyback program

ANAB Rewards

Outperform the market

ANAB Rewards

Earnings are forecast to grow

Linked to ANAB

Symbol

IQ

Close

Change

MLTX

2.97

13.15

+3.79%

ANAB Stock IQ

Login to unlock AnaptysBio (ANAB) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$36.16 (+16.01%)

$20.33 (+106.35%)

$23.75 (+76.63%)

$24.85 (+68.81%)

1year

6month

3month

1month

ANAB Analysts Opinion

ANAB Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

ANAB Analysts Opinion

ANAB Analysts opinion is positive and also has improved from the past 3 months

ANAB Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

56%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

75%

0%

100%

ANAB Street Sentiment

ANAB Street Sentiment is bullish and have positive views on the near-term outlook

ANAB Risk Level

ANAB has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

High volatilty

Low

LOW

HIGH

ANAB Performance Sentiment

Sentiments overview associated with ANAB events and the stock performance.

56%

41%

Positive

Negative

15 out of 27
events present

11 out of 27
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$39.61

Resistance
Price

$29.63

Current Price Range

N/A

Show methods +

ANAB Latest Analysis

AnaptysBio Buckles After Trading Legal Barbs With Pharma Giant GSK. AnaptysBio stock buckled Friday after the biotech company and GSK filed competing lawsuits against one another over a licensing deal.The post AnaptysBio Buckles After Trading Legal Barbs With Pharma Giant GSK appeared first on Investor'.s Business Daily.

Fri Nov 21, 2025

$39.61 | +5.15%

Activity

GSK Unit Tesaro Sues AnaptysBio Threatening Key Cancer Drug Jemperli Royalties. ) subsidiary ANAB) in the Delaware Chancery Court.ANAB is encountering selling pressure. GSK Tesaro in December 2018 for approximately $5.1 billion (4.0 billion British pounds)The action contends that recent conduct by AnaptysBio is in material breach of the existing license agreement with TESARO regarding the Jemperli (dostarlimab).The breach entitles TESARO to terminate the current license agreement obtain a perp

Fri Nov 21, 2025

$39.61 | +5.15%

Activity

Momentum

AnaptysBio drops as litigation with GSK unit risks cancer therapy deal.

Fri Nov 21, 2025

$39.61 | +5.15%

Momentum

GSK subsidiary TESARO files lawsuit against AnaptysBio over Jemperli license.

Fri Nov 21, 2025

$39.61 | +5.15%

Activity

AnaptysBio stock falls after filing lawsuit against GSK unit.

Fri Nov 21, 2025

$39.61 | +5.15%

Activity

Momentum

AnaptysBio drops after litigation with GSK unit risks cancer therapy deal.

Fri Nov 21, 2025

$39.61 | +5.15%

Momentum

AnaptysBio sets $100M stock repurchase plan.

Fri Nov 21, 2025

$39.61 | +5.15%

Activity

AnaptysBio Approves Amended $100 Mln Stock Repurchase Plan . (RTTNews) - AnaptysBio Inc. (ANAB) a clinical-stage biotechnology company on Friday said its Board has approved an amended stock repurchase plan allowing the company to buy back up to $100 million of its stock.

Fri Nov 21, 2025

$39.61 | +5.15%

Activity

Potential

TESARO Pursues Litigation Against AnaptysBio For Alleged Material Breach Of Jemperli Agreement . (RTTNews) - GSK plc.s (GSK) subsidiary TESARO Inc. has commenced litigation against AnaptysBio Inc. (ANAB) contending that AnaptysBio has materially violated the terms of their licensing agreement related to the oncology drug Jemperli.

Fri Nov 21, 2025

$39.61 | +5.15%

Activity

GSKs Tesaro Sues AnaptysBio Over Jemperli License Dispute . (RTTNews) - GSK plc (GSK) a biopharmaceutical companys subsidiary Tesaro Inc. (TSRO) on Friday announced that it has filed litigation in the Delaware Chancery Court against AnaptysBio Inc. (ANAB) alleging a material breach of their license agreement covering the oncology dr

Fri Nov 21, 2025

$39.61 | +5.15%

Activity

Discover ANAB Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ANAB. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ANAB Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ANAB Stock trends

ANAB Stock performance

ANAB Stock analysis

ANAB investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ANAB

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ANAB

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

ANAB Stock Analysis & IQ Rating | AnaptysBio

ANAB Stock IQ

ANAB Target Price

ANAB Risk Level

ANAB Analysts Opinion

ANAB Street Sentiment

ANAB Performance Sentiment

Technical Price Levels

Explore our ANAB Stock insights

Receive our ANAB Daily Alerts

ANAB Stock IQ

ANAB Street Sentiment

ANAB Risk Level

Technical Price Levels

Discover ANAB Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ANAB. We're here to help you make informed investment decisions today.

Receive our ANAB Daily Alerts

ANAB Runner Alarm